Angiofollicular Lymph Hyperplasia - 22 Studies Found

Active, not recruiting : A Study to Evaluate the Safety of Long-term Treatment With Siltuximab in Patients With Multicentric Castleman's Disease
: Multicentric Castleman's Disease
: 2011-04-21
: Drug: Siltuximab Type=exact number, unit=mg/kg, number=11, form=intravenous solution, route=intravenous.
Completed : A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment
: Castleman's Disease
: 2010-08-13
: Drug: tocilizumab [RoActemra/Actemra] maintenance dose
Active, not recruiting : A Study to Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease
: Multicentric Castleman's Disease
: 2009-11-30
:
  • Drug: Siltuximab Siltuximab 11
Withdrawn : Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease
: Giant Lymph Node Hyperplasia
: 2006-08-08
: Drug: Valganciclovir valganciclovir open label, two 450mg tablets orally, twice a day
Completed : Tocilizumab for KSHV-Associated Multicentric Castleman Disease
:
  • Castleman Disease
  • Castleman's Disease : 2011-09-24
    :
    • Drug: Zidovudine Zidovudine (A
Completed : TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial
: Multicentric Castleman Disease
: 2017-01-31
: Drug: Thalidomide, cyclophosphamide and prednisone

Terminated : Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy
:
  • HIV Infections
  • Giant Lymph Node Hyperplasia

: 2005-08-04
: Drug: Rituximab
Completed : Unlock the Cell: Castleman's Disease Flow Cytometry Study
:
  • Castleman Disease
  • Angiofollicular Lymphoi
    : 2016-07-15
    : Procedure: Blood draw/buccal swab The research project will need a blood sample of no more than 50mL per
Completed : Castleman Disease Collaborative Network Biobank
:
  • Castleman Disease
  • Castleman's Disease : 2016-08-15
    : Other: Sample Collection Excess blood sample tubes and/or buccal swabs or saliva will have DNA and RNA e
Completed : A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease
:
  • Lymphoma, Non-Hodgkin
  • Multiple Myeloma